Literature DB >> 13680032

The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology.

Ann-Charlotte Eklöf1, Ann-Mari Thurelius, Mats Garle, Anders Rane, Folke Sjöqvist.   

Abstract

With the support of the Swedish National Institute of Health a national information service was started in 1993 aiming to capture the abuse of doping agents in the general public. It was organized as a telephone service, called the Anti-Doping Hot-Line, from our department and managed by trained nurses co-operating with clinical pharmacologists. Important information collected about all callers (anonymous) was: date of call, its origin, category of caller, doping experience and main question being asked. Abusers were asked about their age, sex, affiliation, abused drug(s), duration of abuse, habit of administration and adverse reactions (ADRs). Between October 1993 and December 2000 25,835 calls were received with a peak during spring and autumn. Most calls (12,400) came from non-abusers, 60% being males. Callers connected with gyms represented the largest group (30%). Most calls about specific drugs concerned anabolic androgenic steroids (AAS). Other drugs or products included ephedrine, clenbuterol and creatine. The most commonly abused anabolic steroids were testosterone, nandrolone-decanoate, methandienone and stanozolol. The ten most commonly reported ADRs of AAS were aggressiveness (835), depression (829), acne (770), gynecomastia (637), anxiousness (637), potency problems (413), testicular atrophy (404), sleep disorders (328), fluid retention (318) and mood disturbances (302). Female side effects included menstruation disturbances, hair growth in the face, lower voice and enlarged clitoris. During the period 1996-200, totally 4339 persons reported about 10,800 side effects. This figure should be compared with the very low number of ADRs (27) reported by prescribers to the Swedish ADR committee during the same period. Abuse of doping agents appears to be a new public health problem that needs detection, medical care and prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680032     DOI: 10.1007/s00228-003-0633-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects.

Authors:  A M Kindlundh; B Hagekull; D G Isacson; F Nyberg
Journal:  Eur J Public Health       Date:  2001-09       Impact factor: 3.367

Review 2.  Anabolic agents.

Authors:  J E Sturmi; D J Diorio
Journal:  Clin Sports Med       Date:  1998-04       Impact factor: 2.182

3.  [Doping - a medical and ethical problem].

Authors:  A Ljungqvist; I Björkhem; B Eriksson; F Sjöqvist; C E Elwin; H Ek; O Lantto; M Garle; S Krievins
Journal:  Lakartidningen       Date:  1982-03-31

4.  Neuropsychiatric effects of anabolic steroids in male normal volunteers.

Authors:  T P Su; M Pagliaro; P J Schmidt; D Pickar; O Wolkowitz; D R Rubinow
Journal:  JAMA       Date:  1993-06-02       Impact factor: 56.272

5.  Personality profile of men using anabolic androgenic steroids.

Authors:  N Galligani; A Renck; S Hansen
Journal:  Horm Behav       Date:  1996-06       Impact factor: 3.587

  5 in total
  20 in total

1.  The clinical pharmacology departments should develop their services according to the local health care needs.

Authors:  Slobodan M Jankovic
Journal:  Eur J Clin Pharmacol       Date:  2004-06-17       Impact factor: 2.953

Review 2.  Androgens and doping tests: genetic variation and pit-falls.

Authors:  Anders Rane; Lena Ekström
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

3.  Modafinil in sports: ethical considerations.

Authors:  K R Kaufman
Journal:  Br J Sports Med       Date:  2005-04       Impact factor: 13.800

Review 4.  [Doping. High-tech cheating in sport].

Authors:  H Striegel; P Simon
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

Review 5.  Steroidogenesis in the skin: implications for local immune functions.

Authors:  Andrzej Slominski; Blazej Zbytek; Georgios Nikolakis; Pulak R Manna; Cezary Skobowiat; Michal Zmijewski; Wei Li; Zorica Janjetovic; Arnold Postlethwaite; Christos C Zouboulis; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2013-02-19       Impact factor: 4.292

Review 6.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 7.  Skin steroidogenesis in health and disease.

Authors:  Georgios Nikolakis; Constantine A Stratakis; Theodora Kanaki; Andrej Slominski; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

8.  Role of HPA and the HPG Axis Interaction in Testosterone-Mediated Learned Helpless Behavior.

Authors:  Birgit Ludwig; Bhaskar Roy; Yogesh Dwivedi
Journal:  Mol Neurobiol       Date:  2018-04-28       Impact factor: 5.590

9.  Effects of anabolic androgenic steroids on sleep patterns of individuals practicing resistance exercise.

Authors:  Daniel Paulino Venâncio; Sergio Tufik; Silvério Aparecido Garbuio; Antonio Claudio Lucas da Nóbrega; Marco Túlio de Mello
Journal:  Eur J Appl Physiol       Date:  2007-11-28       Impact factor: 3.078

10.  The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports.

Authors:  Kurt Skårberg; Fred Nyberg; Ingemar Engström
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.